Potential of diffusion imaging in brain tumors: A review

Acta Radiologica

Volumn 47, Issue 6, 2006, Pages 585-594

  Bode, M K ^a   Ruohonen, J ^a   Nieminen, M T ^a   Pyhtinen, J ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Brain brain stem; CNS; MR diffusion perfusion; Neoplasms primary, metastases

Indexed keywords

MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; MICROSCOPIC EXAMINATION; PATHOLOGY; TUMORS;

BRAIN/BRAIN STEM; CNS; MR DIFFUSION/PERFUSION; NEOPLASMS - PRIMARY, METASTASES;

BRAIN;

ASTROCYTOMA; BRAIN; BRAIN TUMOR; DIFFUSION WEIGHTED IMAGING; GLIOBLASTOMA; HUMAN; MENINGIOMA; METABOLISM; METHODOLOGY; REVIEW;

ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; GLIOBLASTOMA; HUMANS; MENINGIOMA;

EID: 33745728063     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850600580598     Document Type: Article

References (64)

1. Andersen C, Astrup J, Gyldensted C. Quantitative MR analysis of glucocorticoid effects on peritumoral edema associated with intracranial meningiomas and metastases. J Comput Assist Tomogr 1994; 18:509-18.
2. Andersen C, Haselgrove JC, Doenstrup S, Astrup J, Gyldensted C. Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging. Acta Neurochir (Wien) 1993;122:218-24.
3. Asao C, Korogi Y, Kitajima M, Hirai T, Baba Y, Makino K, et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. Am J Neuroradiol 2005;26:1455-60.
4. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45:169-84.
5. Basser PJ, Jones DK. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 2002;15:456-67.
6. Bastin ME, Delgado M, Whittle IR, Cannon J, Wardlaw JM. The use of diffusion tensor imaging in quantifying the effect of dexamethasone on brain tumours. Neuroreport 1999;10:1385-91.
7. Bastin ME, Sinha S, Whittle IR, Wardlaw JM. Measurements of water diffusion and T1 values in peritumoural oedematous brain. Neuroreport 2002; 13:1335-40.
8. Batra A, Tripathi RP, Gorthi SP. Magnetic resonance evaluation of cerebral toxoplasmosis in patients with the acquired immunodeficiency syndrome. Acta Radiol 2004;45:212-21.
9. Bitzer M, Klose U, Geist-Barth B, Nagele T, Schick F, Morgalla M, et al. Alterations in diffusion and perfusion in the pathogenesis of peritumoral brain edema in meningiomas. Eur Radiol 2002;12:2062-76.
10. Bradac GB, Ferszt R, Bender A, Schorner W. Peritumoral edema in meningiomas. A radiological and histological study. Neuroradiology 1986;28:304-12.
11. Bruening R, Kwong KK, Vevea MJ, Hochberg F, Cher L, Harsh GR, et al. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. Am J Neuroradiol 1996;7:831-40.
12. Bulakbasi N, Guvenc I, Onguru O, Erdogan E, Tayfun C, Ucoz T. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004;28: 735-46.
13. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. Am J Neuroradiol 2003;24:225-33.
14. Camacho DL, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. Am J Neuroradiol 2003;24:633-7.
15. Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 2001;22:60-4.
16. Chenevert TL, Meyer CR, Moffat BA, Rehemtulla A, Mukherji SK, Gebarski SS, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 2002; 1:336-43.
17. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-66.
18. Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-36.
19. Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 2004;46:619-27.
20. Conturo TE, McKinstry RC, Aronovitz JA, Neil JJ. Diffusion MRT: precision, accuracy and flow effects. NMR Biomed 1995;8:307-32.
21. Desprechins B, Stadnik T, Koerts G, Shabana W, Breucq C, Osteaux M. Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. Am J Neuroradiol 1999;20:1252-7.
22. Dong Q, Welsh RC, Chenevert TL, Carlos RC, MalySundgren P, Gomez-Hassan DM, et al. Clinical applications of diffusion tensor imaging. J Magn Reson Imaging 2004;19:6-18.
23. Essig M, Knopp MV, Schoenberg SO, Hawighorst H, Wenz F, Debus J, et al. Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;210:551-7.
24. Field AS, Alexander AL, Wu YC, Hasan KM, Witwer B, Badie B. Diffusion tensor eigenvector directional color imaging patterns in the evaluation of cerebral white matter tracts altered by tumor. J Magn Reson Imaging 2004;20:555-62.
25. Gonzalez RG, Schaefer PW, Buonanno FS, Schwamm LH, Budzik RF, Rordorf G, et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210:155-62.
26. Grumme T, Kluge W, Kretzschmar K, Roesler A. Neoplasms. In, Cerebral and spinal computed tomography. Berlin, Vienna: Blackwell Wissenschafts- Verlag, 1998:138-77.
27. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177-83.
28. Hakumäki JM, Poptani H, Puumalainen AM, Loimas S, Paljärvi LA, Ylä-Herttuala S, et al. Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998;58:3791-9.
29. Hein PA, Eskey CJ, Dunn JF, Hug EB. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. Am J Neuroradiol 2004;25:201-9.
30. Howe FA, Opstad KS. 1 H MR spectroscopy of brain tumours and masses. NMR Biomed 2003;16:123-31.
31. Håltas S, Geijer B, Strömblad L-G, Maly-Sundgren P, Burtscher IM. A ring-enhancing metastasis with central high signal on diffusion-weighted imaging and low apparent diffusion coefficients. Neuroradiology 2000;42:824-7.
32. Kim YJ, Chang KH, Song IC, Kim HD, Seong SO, Kim YH, et al. Brain abscess and necrotic or cystic brain tumor: discrimination with signal intensity on diffusion-weighted MR imaging. Am J Roentgenol 1998; 171:1487-90.
33. Knauth M, Forsting M, Hartmann M, Heiland S, Balzer T, Sartor K. MR enhancement of brain lesions: increased contrast dose compared with magnetisation transfer. Am J Neuroradiol 1996;17:1853-9.
34. Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, et al. The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 2001;22:1081-8.
35. Krabbe K, Gideon P, Wagn P, Hansen U, Thomsen C, Madsen F. MR diffusion imaging of human intracranial tumours. Neuroradiology 1997;39:483-9.
36. Lai PH, Ho JT, Chen WL, Hsu SS, Wang JS, Pan HB, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. Am J Neuroradiol 2002;23:1369-77.
37. Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: Does it have any role in the preoperation determination of grading of glioma? Clin Radiol 2002;57:219-25.
38. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991;7:1-30.
39. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. Am J Neuroradiol 2003;24:937-41.
40. Lu S, Ahn D, Johnson G, Law M, Zagzag D, Grossman RT. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004;232:221-8.
41. Mardor Y, Pfeffer R, Spiegelmann R, Roth Y, Maier SE, Nissim O, et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging. J Clin Oncol 2003;21:1094-100.
42. Mardor Y, Roth Y, Lidar Z, Jonas T, Pfeffer R, Maier SE, et al. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 2001;61:4971-3.
43. Mardor Y, Roth Y, Ochersvilli A, Spiegelmann R, Tichler T, Daniels D, et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 2004;6:136-42.
44. Minamikawa S, Kono K, Nakayama K, Yokote H, Tashiro T, Nishio A, et al. Glucocorticoid treatment of brain tumor patients: changes of apparent diffusion coefficient values measured by MR diffusion imaging. Neuroradiology 2004;46:805-11.
45. Noguchi K, Watanabe N, Nagayoshi T, Kanazawa T, Toyoshima S, Shimizu M, et al. Role of diffusion-weighted echo-planar MRI in distinguishing between brain abscess and tumour: a preliminary report. Neuroradiology 1999;41:171.
46. Okamoto K, Ito J, Ishikawa K, Sakai K, Tokiguchi S. Diffusion-weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur Radiol 2000;10:1342-50.
47. Park SH, Chang KH, Song IC, Kim YJ, Kim SH, Han MH. Diffusion-weighted MRI in cystic or necrotic intracranial lesions. Neuroradiology 2000;42:716-21.
48. Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, et al. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas? J Magn Reson Imaging 2004;20:758-64.
49. Price SJ, Burnet NG, Donovan T, Green HA, Pena A, Antoun NM, et al. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion? Clin Radiol 2003;58:455-62.
50. Price SJ, Pena A, Burnet NG, Jena R, Green HA, Carpenter TA, et al. Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas. Eur Radiol 2004;14:1909-17.
51. Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004;232:451-60.
52. Quadery FA, Okamoto K. Diffusion-weighted MRI of haemangioblastomas and other cerebellar tumours. Neuroradiology 2003;45:212-19.
53. Rosenbloom M, Sullivan EV, Pfefferbaum A. Using magnetic resonance imaging and diffusion tensor imaging to assess brain damage in alcoholics. Alcohol Res Health 2003;27:146-52.
54. Ross B, Chenevert T, Kim B, Ben-Yoseph O. Magnetic resonance imaging and spectroscopy: application to experimental neuro-oncology. Q Magn Reson Biol Med 1994;1:89-106.
55. Sadeghi N, Camby I, Goldman S, Gabius HJ, Baleriaux D, Salmon I, et al. Effect of hydrophilic components of the extracellular matrix on quantifiable diffusion-weighted imaging of human gliomas: preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level. Am J Roentgenol 2003;181:235-41.
56. Sartor K. MR imaging of the brain: tumours. Eur Radiol 1999;9:1047-54.
57. Sinha S, Bastin ME, Wardlaw JM, Armitage PA, Whittle IR. Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI study. J Neurol Neurosurg Psychiatry 2004;75:1632-5.
58. Sinha S, Bastin ME, Whittle IR, Wardlaw JM. Diffusion tensor MR imaging of high-grade cerebral gliomas. Am J Neuroradiol 2002;23:520-7.
59. Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. Am J Neuroradiol 2001;22:969-76.
60. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9: 53-60.
61. Tzika A, Astrakas LG, Zarifi MK, Petridou N, Young-Poussaint T, Goumnerova L, et al. Multiparametric MR assessment of pediatric brain tumors. Neuroradiology 2003;45:1-10.
62. Yamasaki F, Kurisu K, Satoh K, Arita K, Sugiyama K, Ohtaki M, et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235: 985-91.
63. Yang D, Korogi Y, Sugahara T, Kitajima M, Shigematsu Y, Liang L, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44: 656-66.
64. Yuh WTC, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ. The effect of contrast dose, imaging time, and lesion size in the MR detection intracerebral metastasis. Am J Neuroradiol 1995;16: 373-80.